§01 Browse › MOTS-c

MOTS-c

Mitochondrial ORF of the 12S rRNA type-c Mitochondrial peptide
Research Compound

MOTS-c is a mitochondria-derived peptide encoded by the mitochondrial genome. It acts as a metabolic regulator that improves insulin sensitivity, enhances exercise tolerance, promotes fat metabolism, and appears to have meaningful anti-aging and stress-resilience effects.

Levels decline with age. It translocates to the nucleus during metabolic stress and exercise, regulating gene expression related to energy metabolism, antioxidant response, and mitochondrial function. In both animal studies and early human research it improves glucose uptake independently of insulin, making it particularly interesting for metabolic health and endurance performance.

Protocol Why Use It Comparison Safety
Warning
Limited human data; this is still an emerging research area · May improve insulin sensitivity, so monitor glucose if stacking it with compounds that affect glucose
Why people use it

MOTS-c is chosen by users who are thinking seriously about metabolic health and longevity rather than short-term performance. Improved insulin sensitivity, fat metabolism, and energy substrate utilization are the primary appeals. Endurance athletes find it interesting for its effects on exercise tolerance and mitochondrial efficiency.

Protocol & usage
  • Reconstitute with bacteriostatic water per vial instructions; swirl gently.
  • Inject subcutaneously. Most self-experimenters use 5–15 mg per dose.
  • Frequency in practice ranges from daily to 3–4 × per week.
  • Best used as part of a broader metabolic health strategy. Combine with consistent exercise for potentially synergistic effects.
  • Keep reconstituted peptide refrigerated; discard after 30 days.
Timeline & expectations

The feedback tends to be improved energy, better glucose handling, and possibly improved body composition over extended periods rather than dramatic acute effects. It is not the compound for someone who wants to feel something strongly within a week.

Notes

Use context

MOTS-c is interesting for a different reason than most peptides. It is not derived from an obvious pharmacological target. It is a peptide the body makes naturally that declines with age, and restoring or supplementing it may address some of the metabolic and mitochondrial deterioration that aging and hard training cause over time.

The exercise connection is particularly relevant for performance users. MOTS-c levels rise naturally during exercise, and the peptide appears to mediate some of exercise’s metabolic benefits at the cellular level. Exogenous administration may theoretically extend this effect beyond what training alone provides.

Common mistakes

Expecting dramatic or fast effects from a peptide whose mechanism is fundamentally about metabolic efficiency over time. Stacking it without awareness of the additive insulin-sensitizing effects of other compounds in the stack.

Comparison notes

Compared with MK-677, MOTS-c addresses metabolic health through a completely different, mitochondria-centric mechanism without the appetite stimulation and water retention. Compared with NAD+ precursors, it works upstream and in parallel, and the combination is used by some users interested in comprehensive mitochondrial support.

Safety & monitoring
Side effects

  • Minimal reported side effects in current literature

  • Theoretical hypoglycemic risk when stacking with insulin-sensitizing compounds

Monitoring

  • fasting glucose and insulin sensitivity markers

  • HbA1c if long-term metabolic monitoring

Avoid if

  • Users stacking multiple insulin-sensitizing agents without glucose monitoring

Add to Cycle Builder ← Browse